The National Accounts 2022 Pre-certification list has been published. Please note, providers should continue to verify member eligibility and benefits prior to rendering services.

 

1291-0921-PN-CNT

Join us in a Continuing Medical Education (CME) webinar series as we share practices and success stories to overcoming barriers in achieving clinical quality goals, attaining better patient outcomes and improving STARS ratings.

 

• Learn strategies to help you and your healthcare team improve your performance across a range of clinical areas.
  
  
• Apply the knowledge you gain from the webinars to improve your organization’s quality and STARs ratings.

 

Attendees will receive one CME credit upon completion of a program evaluation at the conclusion of each webinar.

 

REGISTER HERE for our upcoming clinical quality webinars!

 

1301-0921-PN-CNT

Achieve 90% patient statin therapy adherence with a personalized approach

 

Adults 40–75 years of age with diabetes, who do or do not have clinical atherosclerotic cardiovascular disease (ASCVD), should be started on a statin for primary and secondary prevention of ASCVD regardless of lipid status.¹

 

Studies show that statin use reduces comorbidities and mortality from heart disease and

non-adherence to statins may increase cardiovascular events and even death.²

 

Clinicians play a powerful role in ensuring their patients are adherent to their statin therapies.

In fact, 90% of patients can be successfully adherent to statin therapy with a personalized approach.

 

We created this video to offer clinicians best practices in helping their patients remain adherent to their statin therapies.

 

The following seven strategies can help increase adherence to statin therapy in your patients:

 

1. Initiate statin therapy for patients with diabetes or clinical ASCVD as appropriate

• For diabetics without ASCVD, use MODERATE INTENSITY statin for primary prevention.²
• For diabetics with ASCVD, use HIGH INTENSITY statin for secondary prevention.¹
• Low Intensity statins are not recommended unless unable to tolerate moderate or high intensity.⁴

 

Medications One of the following medications must have be dispensed to satisfy the SUPD measure.
Drug Category	Medications
Statin medication	Lovastatin Fluvastatin Pravastatin Simvastatin Rosuvastatin Atorvastatin Pitavastatin
Statin combination products	Atorvastatin / amlodipine Atorvastatin / ezetimibe Lovastatin / niacin Simvastatin / ezetimibe Simvastatin / niacin Simvastatin / sitagliptin
Timeframe	Standard exclusion(s)
Any time during the measurement year	End-stage renal disease Hospice Rhabdomyolysis or myopathy Pregnancy, lactation, or fertility Liver disease Pre-diabetes Polycystic ovary syndrome (PCOS)

 

2. If a statin is not suitable for a patient, document exclusion criteria with the appropriate

    ICD-10 code

3. Educate patients about the long-term cardiovascular benefits of statin therapy and

    potential side effects 

4. Try a lower dose, different statin, or consider intermittent statin therapy if there were

    previous statin-associated side effects

 

Intensity and Dose of Statin Therapy
High Intensity	Moderate Intensity	Low Intensity
Daily dose lowers LDL-C on average by ≈ ≥50%	Daily dose lowers LDL-C on average by ≈ 30% to <50%	Daily dose lowers LDL-C on average by <30%
Atorvastatin 40-80 mg Rosuvastatin 20-40 mg	Atorvastatin 10-20 mg Rosuvastatin 5-10 mg Simvastatin 20-40 mg Pravastatin 40-80 mg Lovastatin 40 mg Fluvastatin XL 80 mg Fluvastatin 40 mg bid Pitavastatin 2-4 mg	Simvastatin 10 mg Pravastatin 10-20 mg Lovastatin 20 mg Fluvastatin 20-40 mg Pitavastatin 1 mg

 

5. Inform patients that a significant number of generic statin medications are available

    for $0 for a 90-day supply on most plans

 

6. Encourage patients to use their plan ID card to fill statin medications

 

7. Watch this video to learn best practices on helping improve statin therapy adherence

    and your organization’s overall quality and STARS performance.

 

References:

1 2013 ACC/AHA Prevention Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults, A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1-S45, June 24, 2014. https://www.ahajournals.org/doi/pdf/10.1161/01.cir.0000437738.63853.7a

2 American College of Cardiology, The New 2017 American Diabetes Statement on Standards of Medical Care in Diabetes: Reducing Cardiovascular Risk in Patients with Diabetes, May 22, 2017. https://www.acc.org/latest-in-cardiology/articles/2017/05/22/11/00/new-2017-american-diabetes-statement-on-standards-of-medical-care-in-diabetes

3 CMS, 2019 Medicare-Medicaid Plan Performance Data Technical Notes. https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-Coordination/Medicare-Medicaid-Coordination Office/FinancialAlignmentInitiative/Downloads/MMPPerformanceDataTechNotes.pdf

4 Cochrane Database Syst Rev. 2013:CD004816

 

1304-0921-PN-CNT

Did you know the cost Impact of medication non-adherence is $528 billion from non-optimized medication therapy?¹ That’s equivalent to 16% of U.S. total health expenditures and contributes to 275,689 deaths per year.²

 

As a healthcare provider, you can motivate your patients to adhere to their medication regimens, which can contribute to improved outcomes and increased STARS performance. Lack of medication adherence also negatively impacts your STARs performance, which in turn can negatively impact your reimbursement.

 

We developed this video to offer best practices in boosting medication adherence among your patient population.

 

Use the six SIMPLE strategies below to help improve medication adherence among your patient population.

S – Simplify the regimen

• Limit the # of doses and frequency
• Encourage adherence aids such as a pill box
• Utilize generic prescriptions if clinically appropriate
• Implement real-time pharmacy benefit to understand patient cost-share at the point of care

I – Impart knowledge

• Assess patient’s knowledge of medication regimen
• Provide clear medication instructions (written and verbal)
• Patient-provider shared decision-making

M – Modify patient beliefs and behavior

• Ask open ended questions about impact of not taking medications
• Empower patients to self-manage their condition

P – Provide communication and trust

• Provide emotional support
• Allow adequate time for the patient to ask question

L – Leave the bias

• Understand patient’s health literacy and how it affects outcomes
• Develop a patient-centered communication styles

E – Evaluate adherence

• Utilize motivational interviewing to confirm adherence
• Review pharmacy refill records, prescription bottles, lab testing
• Identify barriers to adherence
• Determine interventions and follow-up
• When appropriate, prescribe 90-day fills for chronic conditions  

 

Watch this video to learn more best practices on helping improve medication adherence and your organization’s overall quality and STARS performance.

 

References:

1 Lloyd J et al. How much does medication nonadherence cost the Medicare fee-for-service program? Med Care. 2019;00:1-7.

2 Watannabe JE et al. Cost of prescription drug-related morbidity and mortality. Ann Pharmacother. 2018;52(9):829-837. DOI: 10.1177/1060028018765159

 

1305-0921-PN-CNT

Be Antibiotic Aware campaign offers a prescription solution to antibiotics

 

A mother has a sick child and like all good mothers, wants comfort and care. And a prescription for antibiotics. BMJ Journals published a study that rated how many patients with upper respiratory infections (URI) prior to consultation with their physician expected a prescription for antibiotics¹.

 

Evidence-based data does not support the use of antibiotics in the treatment of the common cold because they do not improve symptoms or shorten the course of the illness.²

 

Instead of putting away the prescription pad, use this one.

 

Offered by the CDC’s Be Antibiotics Aware campaign, the “Relief for common symptoms of colds and cough” prescription pad provides an alternative to unnecessary antibiotics. Get it through the CDC website here.

 

Measure up: HEDIS® guidelines for URI/Pharyngitis

URI measures the percentage of episodes for members 3 months of age and older with a URI diagnosis that did not result in an antibiotic dispensing event.

 

Appropriate testing for pharyngitis (CWP) evaluates members 3 years of age and older where the member was diagnosed with pharyngitis, dispensed an antibiotic and received a group A streptococcus (strep) test for the episode.

 

Records and billing codes

URI: In the patient’s medical records, document results of all strep tests or refusal for testing. If antibiotics are prescribed for another condition, take care to associate the antibiotic with the appropriate diagnosis.

 

Description	CPT/HCPCS/ICD-10
Pharyngitis	ICD-10-CM: J02.0, J02.8, J02.9, J03.00, J03.01, J03.80, J03.81, J03.90, J03.91
URI	ICD-10-CM: J00, J06.0, J06.9
Online assessments	CPT: 98970, 98971, 98972, 99421, 99422, 99423, 99457 HCPCS: G0071, G2010, G2012, G2061, G2062, G2063
Telephone visits	CPT: 98966, 98967, 98968, 99441, 99422, 99423

 

CWP: In the patient’s medical records, document results of all strep tests or refusal for testing. If antibiotics are prescribed for another condition, take care to associate the antibiotic with the appropriate diagnosis.

 

Description	CPT/HCPCS/ICD-10
Pharyngitis	ICD-10-CM: J02.0, J02.8, J02.9, J03.00, J03.01, J03.80, J03.81, J03.90, J03.91
Group A streptococcal tests	CPT: 87070, 87071, 87081, 87430, 87650-87652, 87880 LOINC: 11268-0, 17656-0, 17898-8, 18481-2, 31971-5, 49610-9, 5036-9, 60489-2, 626-2, 6557-3, 6558-1, 6559-9, 68954-7, 78012-2
Online assessments	CPT: 98970, 98971, 98972, 99421, 99422, 99423, 99457 HCPCS: G0071, G2010, G2012, G2061, G2062, G2063
Telephone visits	CPT: 98966, 98967, 98968, 99441, 99422, 99423

 

References:

1 BMJ Journals. Medical management of acute upper respiratory infections in an urban primary care out of hours facility: cross-sectional study of patient presentation and expectations. https://bmjopen.bmj.com/content/9/2/e025396

2 NCBI. Upper Respiratory Tract Infection. https://www.ncbi.nlm.nih.gov/books/NBK532961/  

 

1306-0921-PN-CNT

Instead of faxing multiple pages of medical records for HEDIS_® studies, use Anthem Blue Cross and Blue Shield (Anthem)’s Remote EMR Access Service we offer to providers that allows us to access your EMR system directly to pull the documentation we need. Our Remote EMR Access Service helps reduce the time and costs associated with medical record retrieval while improving efficiency and lessening the impact on your office staff.

 

We have a centralized EMR team experienced with multiple EMR systems and extensively trained annually on HIPAA, EMR systems, and HEDIS_® measure updates. We complete medical record retrieval based on minimum necessary guidelines:

• We only access medical records of members pulled into the HEDIS_® sample using specific demographic data.
• We only retrieve the medical records that have evidence related to the HEDIS_® measures.
• We only view face sheets when there are demographic discrepancies.
• We exclude data related to hospice, long-term care, inpatient, and palliative care.

 

Let us help you! Getting started with Remote EMR Access is just one click away.

Download and complete this registration form and email it to us at Centralized_EMR_Team@anthem.com.

 

To learn more about our Remote EMR Access Service, view the Frequently Asked Questions below.

 

How do you retrieve our medical records?
We access your EMR using a secure portal and retrieve only the necessary documentation by printing to an electronic file we store internally, on our secure network drives.

 

Is printing necessary?
Yes. The NCQA audit requires print-to-file access.

 

Is this process secure?
Yes. We only use secure internal resources to access your EMR systems. All retrieved records are stored on Anthem secure network drives.

 

Why does Anthem need full access to the entire medical record?
There are several reasons we need to look at the entire medical record of a member:

• HEDIS_® measures can include up to a 10-year look back at a member’s information.
• Medical record data for HEDIS_® compliance may come from several different areas of the EMR system, including labs, radiology, surgeries, inpatient stays, outpatient visits, and case management.
• Compliant data may be documented or housed in a non-standard format, such as an in-office lab slip scanned into miscellaneous documents

 

What information do I need to submit to use your Remote EMR Access Service?
Complete the registration form that requests the following information:

• Practice/facility demographic information (e.g., address, National Provider ID, taxpayer identification numbers , etc.)
• EMR system information (e.g., type of EMR system, required access forms, access type–web based or VPN-to-VPN connection, special requirements needed for access, etc.)
• List of current providers/locations or a website for accessing this list. Also, if applicable, a list of providers affiliated with the group that are not in the EMR System.

 

HEDIS_® is a registered trademark of the National Committee for Quality Assurance (NCQA).

 

1313-0921-PN-CNT

Please continue to check Provider Communications & Updates on the provider website for the latest BadgerCare Plus information, including:

 

• Clinical Criteria Updates Notification – May 2021
  
  
• CT to detect coronary artery calcification — AIM transition

 

Please continue to read news and updates at anthem.com/medicareprovider for the latest Medicare Advantage information, including:

 

• Clinical criteria updates notification – May 2021

 

Effective November 30, 2021, Anthem Blue Cross and Blue Shield claims for members who leave against medical advice and are admitted to another acute care facility on the same day are considered transfers and will follow the criteria detailed in the policy.

 

For additional information, please review the DRG Inpatient Facility Transfers reimbursement policy at anthem.com/medicareprovider under the Facilities dropdown.

 

ABSCRNU-0240-21

On November 1, 2021, Anthem Blue Cross and Blue Shield (Anthem) prior authorization (PA) requirements will change for L8702 covered by Anthem. Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.

 

PA requirements will be added for the following code:

• L8702 — Powered upper extremity range of motion assist device, elbow, wrist, hand, finger, single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated

 

Not all PA requirements are listed here. Detailed PA requirements are available to contracted providers on the provider website at anthem.com > Login or by accessing Availity.* Once logged in to availity.com, select Patient Registration > Authorizations & Referrals, then choose Authorizations or Auth/Referral Inquiry, as appropriate. Contracted and non-contracted providers who are unable to access Availity may call our Provider Services at the number on the back of your patients’ Anthem ID card for assistance with PA requirements.

 

* Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross and Blue Shield.

 

ABSCRNU-0247-21

The best way to ensure you're submitting everything needed for a prior authorization is to use the prior authorization/precertification form at anthem.com/medicareprovider > Providers > Provider Resources > Forms and Guides. By filling out the form completely and with as much information as possible, you can be sure we have the information to process your request timely.

 

ABSCRNU-0248-21